Clinical Trials Logo
  1. Home
  2. Solid Organ Transplant
  3. NCT00518778
  4. Details
NCT00518778 Clinical Trial

Fusariosis in Solid-Organ Transplant Recipients

Solid Organ Transplant Clinical Trial

Official title:
Fusariosis in Solid-Organ Transplant Recipients

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00518778
Other study ID # PRO07070159
Secondary ID investigator fun
Status Completed
Phase N/A
First received August 17, 2007
Last updated December 2, 2009
Start date August 2007
Est. completion date December 2009

Study information
Verified date December 2009
Source University of Pittsburgh
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

This exempt chart review study will try to determine the clinical presentation, prognostic factors, response to different treatment modalities and mortality among patients diagnosed with fusariosis after solid-organ transplantation.

Description:

This exempt chart review study will try to determine the clinical presentation, prognostic factors, response to different treatment modalities and mortality among patients diagnosed with fusariosis after solid-organ transplantation.This will help determine prognostic factors, response to different treatment modalities and mortality among patients diagnosed with fusariosis after solid-organ transplantation.

Recruitment information / eligibility
Status Completed
Enrollment 50
Est. completion date December 2009
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Solid-organ transplants (liver, kidney, lung, heart, pancreas, small bowel transplant) diagnosed with fusariosis or infections due to Fusarium, species in our institution

Exclusion Criteria:

- Those subjects that do not meet inclusion criteria

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

Locations
Country Name City State
United States University of Pittsburgh Medical Center Pittsburgh Pennsylvania

Sponsors (1)
Lead Sponsor Collaborator
University of Pittsburgh

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Terminated NCT03950414 - A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Solid Organ Transplant Recipients Phase 1
Recruiting NCT05663463 - Seasonal Influenza Vaccine High Dose Boosting in Solid Organ Transplant Recipients N/A
Completed NCT05124509 - Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ Transplant
Completed NCT05121142 - Study of Ruxolitinib for Acute and Chronic Graft Versus Host Disease Phase 1
Completed NCT01058239 - Bortezomib Plus Rituximab for EBV+ PTLD Phase 2
Withdrawn NCT03327987 - Early Flu Shots in SOT
Completed NCT04253548 - iPeer2Peer Pediatric Thoracic Transplantation N/A
Recruiting NCT05164016 - Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
Withdrawn NCT02464306 - Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile Infection Phase 4
Completed NCT02165423 - Discharge to Home and Chronic Illness Care Pilot N/A
Completed NCT00907023 - Transition From Hospital to Home in Solid Organ Transplant (SOT) N/A
Recruiting NCT04613206 - High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients Phase 2
Recruiting NCT05550298 - Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
Active, not recruiting NCT04331275 - Viral Specific T-cells for Treatment of Viral Infections After Solid Organ Transplant Phase 2
Recruiting NCT05968807 - iParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients N/A
Active, not recruiting NCT03482739 - Safety, Tolerability and Immunogenicity of a Nine-valent Human Papillomavirus (HPV) Vaccine in HIV and Transplant Patients Phase 3
Not yet recruiting NCT04721288 - REmote moBile Outpatient mOnitoring in Transplant 2.0 N/A
Completed NCT04844489 - Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People N/A
Active, not recruiting NCT03360682 - Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV‐1‐Infected Solid Organ Transplant Patients Phase 4